Company HLB PANAGENE Co., LTD.

Equities

A046210

KR7046210001

Biotechnology & Medical Research

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Sales per region

Sector Bio Diagnostics & Testing

End-of-day quote Korea S.E. Other stock markets 06:00:00 2024-04-28 pm EDT			5-day change	1st Jan Change
4,225 ^KRW	-1.17%		-6.53%	+2.30%

Jan. 25	Gencurix Inc. announced that it has received KRW 3.99999552 billion in funding from HLB PANAGENE Co., LTD.	CI
Jan. 24	HLB PANAGENE Co., LTD. announced that it has received KRW 2 billion in funding from Gencurix Inc.	CI

HLB PanaGene Co Ltd, formerly Panagene Inc, is a Korea-based company mainly engaged in the development of genetic diagnostic products. The Company operates its business through three segments. The Diagnostics Business segment mainly involves in manufacturing and sales of molecular diagnostic reagents, analysis services, and consumables. The Materials Business segment mainly engages in the manufacturing and sales of custom pentose nucleic acid (PNA) oligomers. The Nucleic Acid Extraction segment mainly engages in the manufacturing and sales of nucleic acid extraction equipment and extraction reagents.

Number of employees: 63

KRW in Million	2022	Weight	2023	Weight	Delta
Genetic Diagnostic Products 88.8 %	12,970	91.5 %	10,881	88.8 %	-16.11%
Genetic Diagnostic Merchandise 8.4 %	1,178	8.3 %	1,031	8.4 %	-12.47%
Service 2.8 %	23	0.2 %	340	2.8 %	+1,368.15%

KRW in Million	2022	Weight	2023	Weight	Delta
South Korea 63.8 %	8,912	62.9 %	7,815	63.8 %	-12.31%
Asia 10.7 %	1,558	11.0 %	1,307	10.7 %	-16.09%
United States 10.2 %	1,595	11.3 %	1,255	10.2 %	-21.31%
Europe 8.2 %	1,373	9.7 %	1,010	8.2 %	-26.44%
Middle East 6.5 %	648	4.6 %	791	6.5 %	+21.98%
Oceania 0.5 %	17	0.1 %	56	0.5 %	+221.66%
Others 0.2 %	68	0.5 %	19	0.2 %	-72.22%

Managers	Title	Age	Since
In-Geun Jang CEO	Chief Executive Officer	48	-
Bong-Ho Eom BRD	Director/Board Member	51	03-07-31
Seung-Gyo Park BRD	Director/Board Member	63	-
Young Lee AUD	Comptroller/Controller/Auditor	54	08-04-13
Chang-Shik Park PRN	Corporate Officer/Principal	77	10-02-15

Members of the board	Title	Age	Since
Chang-Shik Park PRN	Corporate Officer/Principal	77	10-02-15
Jong-Boo Lim BRD	Director/Board Member	63	13-03-28
Yong-Hwan Lee BRD	Director/Board Member	63	17-03-29
Seung-Gyo Park BRD	Director/Board Member	63	-
Bong-Ho Eom BRD	Director/Board Member	51	03-07-31
Sung-Jae Shin BRD	Director/Board Member	49	23-08-02
Joo-Soo Lee BRD	Director/Board Member	61	23-08-02

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	41,014,527	26,071,453 ( 63.57 %)	0	63.57 %

Name	Equities	%	Valuation
HLB CO., LTD. 9.372 %	3,842,743	9.372 %	14 M ₩
Sung-Gi Kim 7.576 %	3,106,485	7.576 %	12 M ₩
June-Gone Park 6.475 %	2,655,000	6.475 %	10 M ₩
Man-ho Cho 2.364 %	969,145	2.364 %	4 M ₩
Atinum Investment Co., Ltd. (Private Equity) 2.343 %	960,855	2.343 %	4 M ₩
Capitalworks Investment Co., Ltd. 1.947 %	798,258	1.947 %	3 M ₩
Myung-chull Kim 1.731 %	709,876	1.731 %	3 M ₩
Young-shik Jeong 1.341 %	550,000	1.341 %	2 M ₩
YB Partners Co., Ltd. 1.151 %	471,909	1.151 %	2 M ₩
NKIA Co., Ltd. 0.9755 %	400,000	0.9755 %	1 M ₩

HLB PANAGENE Co., Ltd.

54 Techno 10-ro Yuseong-gu

34027, Daejeon

http://www.panagene.com

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Bio Diagnostics & Testing

	1st Jan change	Capi.
HLB PANAGENE CO., LTD.	+2.30%	127M
EXACT SCIENCES CORPORATION	-20.55%	10.82B
IOVANCE BIOTHERAPEUTICS, INC.	+47.97%	3.25B
GUARDANT HEALTH, INC.	-32.75%	2.11B
BGI GENOMICS CO., LTD.	-14.15%	2.08B
VERACYTE, INC.	-26.06%	1.48B
MARAVAI LIFESCIENCES HOLDINGS, INC.	+19.85%	1.02B
SEEGENE, INC.	-2.62%	733M
CAREDX, INC	-31.67%	391M
ADAPTIVE BIOTECHNOLOGIES CORPORATION	-43.88%	383M

Bio Diagnostics & Testing